| Dr Teresa White Tranchemontagne, DO | |
|
8 Limbo Lane, Amherst, NH 03031-1735 | |
| (603) 673-5885 | |
| (603) 672-7150 |
| Full Name | Dr Teresa White Tranchemontagne |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 8 Limbo Lane, Amherst, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811081987 | NPI | - | NPPES |
| 30011100 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 10131 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health & Hospice Care | Merrimack, NH | Home health agency |
| Southern Nh Medical Center | Nashua, NH | Hospital |
| St Joseph Hospital | Nashua, NH | Hospital |
| Elliot Hospital | Manchester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
PDL BioPharma, Inc. today announced the allocation between dividend income and return of capital for federal income tax purposes for dividends paid in 2009.
Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
Starting this year, more than 10,000 baby boomers a day will turn 65. As these baby boomers age, one of out of eight of them will develop Alzheimer's – a devastating, costly, heartbreaking disease. Increasingly for these Baby Boomers, it will no longer be their grandparents and parents who have Alzheimer's – it will be them.
The world is now in the grips of a historic pandemic. The death toll from the novel coronavirus has climbed to more than 117,000 in the United States and 448,000 around the world.
› Verified 3 days ago
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
PDL BioPharma, Inc. today announced the allocation between dividend income and return of capital for federal income tax purposes for dividends paid in 2009.
Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
Starting this year, more than 10,000 baby boomers a day will turn 65. As these baby boomers age, one of out of eight of them will develop Alzheimer's – a devastating, costly, heartbreaking disease. Increasingly for these Baby Boomers, it will no longer be their grandparents and parents who have Alzheimer's – it will be them.
The world is now in the grips of a historic pandemic. The death toll from the novel coronavirus has climbed to more than 117,000 in the United States and 448,000 around the world.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa White Tranchemontagne, DO Po Box 3677, Nashua, NH 03061-3677 Ph: (603) 577-7900 | Dr Teresa White Tranchemontagne, DO 8 Limbo Lane, Amherst, NH 03031-1735 Ph: (603) 673-5885 |
News Archive
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
PDL BioPharma, Inc. today announced the allocation between dividend income and return of capital for federal income tax purposes for dividends paid in 2009.
Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
Starting this year, more than 10,000 baby boomers a day will turn 65. As these baby boomers age, one of out of eight of them will develop Alzheimer's – a devastating, costly, heartbreaking disease. Increasingly for these Baby Boomers, it will no longer be their grandparents and parents who have Alzheimer's – it will be them.
The world is now in the grips of a historic pandemic. The death toll from the novel coronavirus has climbed to more than 117,000 in the United States and 448,000 around the world.
› Verified 3 days ago
Robert C. Kolodny, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 57 The Flume, Amherst, NH 03031 Phone: 203-981-8424 Fax: 603-672-4495 | |
Dr. Catherine Anne Booher, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Nathan Lord Rd, Amherst, NH 03031 Phone: 410-236-6520 |